[
    [
        {
            "time": "",
            "orginal_text": "多個創新中藥上市",
            "features": {
                "keywords": [
                    "創新中藥",
                    "上市"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "醫藥"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "多個創新中藥上市",
            "scores": {
                "News_content": "多個創新中藥上市",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "超30款1類新藥獲批臨床!來自恆瑞醫藥、百濟神州(06160)、泰德制藥、美雅珂生物等",
            "features": {
                "keywords": [
                    "1類新藥",
                    "臨床試驗",
                    "恆瑞醫藥",
                    "百濟神州",
                    "泰德制藥",
                    "美雅珂生物"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "醫藥"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "超30款1類新藥獲批臨床!來自恆瑞醫藥、百濟神州(06160)、泰德制藥、美雅珂生物等",
            "scores": {
                "News_content": "超30款1類新藥獲批臨床!來自恆瑞醫藥、百濟神州(06160)、泰德制藥、美雅珂生物等",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "orginal_text": "如何尋找長期投資標的？這一指標很關鍵！兩大維度檢驗\"護城河\"，哪些A股擁有這些特質？名單來了",
            "features": {
                "keywords": [
                    "長期投資",
                    "護城河",
                    "A股"
                ],
                "sentiment_score": 0.65,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "如何尋找長期投資標的？這一指標很關鍵！兩大維度檢驗\"護城河\"，哪些A股擁有這些特質？名單來了",
            "scores": {
                "News_content": "如何尋找長期投資標的？這一指標很關鍵！兩大維度檢驗\"護城河\"，哪些A股擁有這些特質？名單來了",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 7,
                "Entity_Density": 3,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        }
    ]
]